Primary Site >> Liver Cancer

Gene >> MYD88

  • 2007
  • 2008
  • 2010
  • 2011
  • 2013
  • 2014
  • 2015
  • 2016
  • 2017
  • 2018
Ref: Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production.
PMID: 17615358
Ref: Is interleukin-6 a gender-specific risk factor for liver cancer?
PMID: 17896415
Ref: Inflammation, HCC and sex: IL-6 in the centre of the triangle.
PMID: 18093689
Ref: [The role of MyD88 in inflammatory/infection-related hepatocellular carcinoma].
PMID: 20380806
Ref: Host mechanisms in viral hepatitis.
PMID: 20460887
Ref: Up-regulated myeloid-derived suppressor cell contributes to hepatocellular carcinoma development by impairing dendritic cell function.
PMID: 20822377
Ref: Hepatitis B virus X protein stimulates IL-6 expression in hepatocytes via a MyD88-dependent pathway.
PMID: 20937539
Ref: S-adenosylmethionine prevents the up regulation of Toll-like receptor (TLR) signaling caused by chronic ethanol feeding in rats.
PMID: 21276439
Ref: miR-22 promotes HBV-related hepatocellular carcinoma development in males.
PMID: 21750200
Ref: Hepatitis B virus impairs TLR9 expression and function in plasmacytoid dendritic cells.
PMID: 22046272
Ref: IL-1beta production through the NLRP3 inflammasome by hepatic macrophages links hepatitis C virus infection with liver inflammation and disease.
PMID: 23633957
Ref: Can Toll-Like Receptor (TLR) 2 be considered as a new target for immunotherapy against hepatitis B infection?
PMID: 24530748
Ref: Toll-like receptor 4 and hepatitis B infection: molecular mechanisms and pathogenesis.
PMID: 25014492
Ref: Tumor necrosis factor-alpha induced by hepatitis B virus core mediating the immune response for hepatitis B viral clearance in mice model.
PMID: 25047809
Ref: Intracellular Osteopontin inhibits toll-like receptor signaling and impedes liver carcinogenesis.
PMID: 25398438
Ref: CXC195 suppresses proliferation and inflammatory response in LPS-induced human hepatocellular carcinoma cells via regulating TLR4-MyD88-TAK1-mediated NF-kappaB and MAPK pathway.
PMID: 25475726
Ref: The therapeutic detoxification of chlorogenic acid against acetaminophen-induced liver injury by ameliorating hepatic inflammation.
PMID: 26079055
Ref: Effects of TLR4 gene silencing on the proliferation and apotosis of hepatocarcinoma HEPG2 cells.
PMID: 27123062
Ref: Hypoxia-inducible factor-1alpha mediates the toll-like receptor 4 signaling pathway leading to anti-tumor effects in human hepatocellular carcinoma cells under hypoxic conditions.
PMID: 27446390
Ref: Role of Osteopontin in Liver Diseases.
PMID: 27570486
Ref: Extracellular Vesicles Including Exosomes Regulate Innate Immune Responses to Hepatitis B Virus Infection.
PMID: 27630638
Ref: Hepatitis B Surface Antigen Promotes the Invasion of Hepatitis B Virus-Related Hepatocellular Carcinoma Cells by Upregulation of Toll-Like Receptor 2.
PMID: 28061318
Ref: Long non-coding RNA Myd88 promotes growth and metastasis in hepatocellular carcinoma via regulating Myd88 expression through H3K27 modification.
PMID: 29022910
Ref: NADPH oxidase 4 modulates hepatic responses to lipopolysaccharide mediated by Toll-like receptor-4.
PMID: 29085012
Ref: Activation of the TLR4/MyD88 signaling pathway contributes to the development of human hepatocellular carcinoma via upregulation of IL-23 and IL-17A.
PMID: 29928340